COVID-19 Updates
Latest News
Pemphigus, Bullous Pemphigoid Risk Increased After COVID-19 Infection
"This potential dual benefit of vaccination should be a key message in public health campaigns and clinical practice," the study authors wrote.
Latest News
New COVID-19 Vaccines That Target KP.2 Variant Available
Two mRNA vaccines target the KP.2 variant, while a third vaccine targets the JN.1 variant, a predecessor to KP.2.
Latest News
ABIM Revokes Two Physicians’ Certifications Over Accusations of COVID Misinformation
Two critical care docs lose ABIM certification following advocating for ivermectin as a treatment for COVID.
Latest News
How Safe is Anti–IL-6 Therapy During Pregnancy?
Transient neonatal cytopenia was the only possible adverse outcome that could be related to anti–IL-6 therapy.
Feature
Federal Trade Commission Bans Noncompete Agreements, Urges More Protections for Healthcare Workers
But dissenting commissioners dispute the FTC’s authority to broadly ban noncompetes.
Latest News
Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief
The drug may not be particularly helpful for patients who are not at high risk for severe COVID-19.
Latest News
Increased Risk of New Rheumatic Disease Follows COVID-19 Infection
While previous studies had identified a link between COVID-19 infection and greater risk of autoimmune disease, a new study is perhaps the largest...
Latest News
Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse Reactions
The EMA has warned that Paxlovid should only be administered alongside tacrolimus, ciclosporin, everolimus, or sirolimus if their blood levels can...
Commentary
Long COVID: Another Great Pretender
The list of symptom is so long and complex and overlaps with so many other illnesses that a definitive diagnosis may be impossible.
Feature
Five Bold Predictions for Long COVID in 2024
If even one of these comes true, long COVID sufferers could enjoy some much-needed relief.
Latest News
Analysis Finds Risk of Alopecia Areata After COVID-19 Infection
The cohort consisted of 259,369 patients with COVID-19 and 259,369 uninfected controls.